{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:40:04Z","timestamp":1793810404991,"version":"4.6.1"},"reference-count":299,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fund for Scientific Research of Flanders"},{"DOI":"10.13039\/501100002749","name":"Belgian Science Policy Office","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Concerted Research Actions of the Regional Government of Flanders","award":["GOA13\/014"],"award-info":[{"award-number":["GOA13\/014"]}]}],"content-domain":{"domain":["cgfr.co.uk","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.cytogfr.2014.11.009","type":"journal-article","created":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T10:53:45Z","timestamp":1416653625000},"page":"311-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":284,"title":["CXCR3 ligands in disease and therapy"],"prefix":"10.1016","volume":"26","author":[{"given":"Katrien","family":"Van Raemdonck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Van den Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Liekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Struyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2014.11.009_bib0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1600-0463.2004.apm11207-0808.x","article-title":"The chemokine system \u2013 a major regulator of angiogenesis in health and disease","volume":"112","author":"Rosenkilde","year":"2004","journal-title":"APMIS"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ni.2812","article-title":"New nomenclature for atypical chemokine receptors","volume":"15","author":"Bachelerie","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.68.1.1","article-title":"CXC chemokines in angiogenesis","volume":"68","author":"Belperio","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000353317","article-title":"Angiogenic and antiangiogenic chemokines","volume":"99","author":"Bosisio","year":"2014","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0035","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0040","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","article-title":"The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity","volume":"165","author":"Addison","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0045","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1840701","article-title":"Structure and functional expression of a human interleukin-8 receptor","volume":"253","author":"Holmes","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0050","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1582-4934.2011.01301.x","article-title":"The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells","volume":"15","author":"Dai","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0055","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Lasagni","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0060","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0065","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes","volume":"184","author":"Loetscher","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0070","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.4049\/jimmunol.173.10.6234","article-title":"Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping","volume":"173","author":"Ehlert","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0075","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2009-11-253591","article-title":"Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3","volume":"117","author":"Struyf","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.72.121801.161747","article-title":"Regulation of protein function by glycosaminoglycans \u2013 as exemplified by chemokines","volume":"74","author":"Handel","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.182.1.219","article-title":"The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation","volume":"182","author":"Luster","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-642-23056-1_13","article-title":"Glycosaminoglycan and chemokine\/growth factor interactions","author":"Shute","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jlb.59.4.545","article-title":"Serglycin-binding proteins in activated macrophages and platelets","volume":"59","author":"Kolset","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0100","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.173.3.2060","article-title":"Platelet factor 4\/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients","volume":"173","author":"Pervushina","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0105","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.4049\/jimmunol.161.8.4347","article-title":"A chondroitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation","volume":"161","author":"Petersen","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0110","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood.V95.4.1158.004k31_1158_1166","article-title":"The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages","volume":"95","author":"Scheuerer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0115","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W","article-title":"Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization","volume":"28","author":"Loetscher","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0125","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.4049\/jimmunol.162.7.3840","article-title":"Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling","volume":"162","author":"Rabin","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1T helper cells (Th1s) and Th2s","volume":"187","author":"Bonecchi","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0140","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.177.9.5890","article-title":"T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity","volume":"177","author":"Taqueti","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/labinvest.3780248","article-title":"CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells","volume":"81","author":"Garcia-Lopez","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0155","first-page":"287","article-title":"a double-edged sword in tumor progression and angiogenesis","volume":"1836","author":"Billottet","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0160","doi-asserted-by":"crossref","first-page":"30219","DOI":"10.1074\/jbc.M403595200","article-title":"Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function","volume":"279","author":"Colvin","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0165","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1182\/blood-2004-01-0214","article-title":"Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11","volume":"107","author":"Dagan-Berger","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0170","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2567.2010.03384.x","article-title":"Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes","volume":"132","author":"Korniejewska","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0175","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/eji.200324235","article-title":"Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation","volume":"33","author":"Xanthou","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0180","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1128\/MCB.00556-06","article-title":"CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis","volume":"26","author":"Colvin","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0185","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1073\/pnas.87.14.5238","article-title":"A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines","volume":"87","author":"Farber","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0190","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1084\/jem.166.4.1084","article-title":"Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)","volume":"166","author":"Luster","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0195","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/labinvest.3700453","article-title":"TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis","volume":"86","author":"Loos","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0200","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/eji.200324136","article-title":"Microbial Toll-like receptor ligands differentially regulate CXCL10\/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis","volume":"33","author":"Proost","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1189\/jlb.1003524","article-title":"Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids","volume":"75","author":"Proost","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0210","doi-asserted-by":"crossref","first-page":"13522","DOI":"10.1074\/jbc.M113.455329","article-title":"Alternative C-Terminal Helix Orientation Alters Chemokine Function: structure of the anti-angiogenic chemokine, CXCL4L1","volume":"288","author":"Kuo","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0215","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/01.RES.0000146674.38319.07","article-title":"Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4\/CXCL4 and potent inhibitor of angiogenesis","volume":"95","author":"Struyf","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0220","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1182\/blood-2006-10-052035","article-title":"PF-4\/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion","volume":"109","author":"Lasagni","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0225","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/cvr\/cvn029","article-title":"Understanding the immunoangiostatic CXC chemokine network","volume":"78","author":"Balestrieri","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2010.10.011","article-title":"The role of the CXC chemokines platelet factor-4 (CXCL4\/PF-4) and its variant (CXCL4L1\/PF-4var) in inflammation, angiogenesis and cancer","volume":"22","author":"Vandercappellen","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.canlet.2008.04.050","article-title":"The role of CXC chemokines and their receptors in cancer","volume":"267","author":"Vandercappellen","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.133.2.275","article-title":"Isolation of a tumor factor responsible for angiogenesis","volume":"133","author":"Folkman","year":"1971","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0250","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrc1693","article-title":"Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis","volume":"5","author":"Cao","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mvr.2013.05.005","article-title":"CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis","volume":"89","author":"Prats","year":"2013","journal-title":"Microvasc Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0260","first-page":"153","article-title":"Role of tumour-associated macrophages in cancer-related inflammation","volume":"32","author":"Sica","year":"2010","journal-title":"Exp Oncol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0265","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00011-013-0645-9","article-title":"Immune system: a double-edged sword in cancer","volume":"62","author":"Lakshmi Narendra","year":"2013","journal-title":"Inflamm Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0270","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cytogfr.2011.09.002","article-title":"The expression and role of CXC chemokines in colorectal cancer","volume":"22","author":"Verbeke","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2004.10.003","article-title":"Cellular characteristics of neuroblastoma cells: regulation by the ELR\u2212-CXC chemokine CXCL10 and expression of a CXCR3-like receptor","volume":"29","author":"Goldberg-Bittman","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0280","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cncr.20747","article-title":"Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma","volume":"103","author":"Suyama","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.imlet.2003.10.020","article-title":"The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines","volume":"92","author":"Goldberg-Bittman","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0290","doi-asserted-by":"crossref","first-page":"45098","DOI":"10.1074\/jbc.M106912200","article-title":"Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells","volume":"276","author":"Robledo","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0295","first-page":"11","article-title":"Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion","author":"Wu","year":"2012","journal-title":"Mol Cancer"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0300","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/1535-7163.MCT-08-0485","article-title":"CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model","volume":"8","author":"Ma","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0305","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1038\/sj.onc.1210267","article-title":"Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes","volume":"26","author":"Kawada","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0310","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.2005.032144","article-title":"CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors","volume":"60","author":"Monteagudo","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI7335","article-title":"The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis","volume":"104","author":"Trentin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0320","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V95.2.627","article-title":"The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia","volume":"95","author":"Jones","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0325","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1182\/blood-2011-03-342436","article-title":"Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia","volume":"118","author":"Yan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3324\/haematol.10649","article-title":"The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells","volume":"92","author":"Ocana","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0335","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood-2011-06-357442","article-title":"Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10","volume":"119","author":"Lee","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0340","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.prp.2012.06.009","article-title":"Evaluation of circulating concentrations of CXCL1 (Gro-alpha), CXCL10 (IP-10) and CXCL12 (SDF-1) in ALL patients prior and post bone marrow transplantation","volume":"208","author":"Khandany","year":"2012","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5956-7-7","article-title":"Discovery and identification of potential biomarkers of pediatric Acute Lymphoblastic Leukemia","author":"Shi","year":"2009","journal-title":"Proteome Sci"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0350","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/blood.V59.1.96.96","article-title":"Translocation 4\u201311 in acute lymphoblastic-leukemia \u2013 clinical characteristics and prognostic-significance","volume":"59","author":"Arthur","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0355","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000132431","article-title":"Human platelet factor 4 gene is mapped to 4q12-q21","volume":"45","author":"Griffin","year":"1987","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0360","first-page":"11","article-title":"Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling","author":"Bai","year":"2013","journal-title":"Proteome Sci"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0365","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1074\/mcp.M700194-MCP200","article-title":"Platelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission","volume":"7","author":"Kim","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0370","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00262-005-0080-z","article-title":"T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC)","volume":"55","author":"Olsnes","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000353406","article-title":"Assay of OAZ1 mRNA levels in chronic myeloid leukemia combined with application of leukemia PCR array identified relevant gene changes affected by antizyme","volume":"131","author":"Wu","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0380","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/1471-2407-11-528","article-title":"Tyrosine kinase chromosomal translocations mediate distinct and overlapping gene regulation events","volume":"11","author":"Kim","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/path.1745","article-title":"Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma","volume":"206","author":"Teichmann","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0390","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/10428190009087027","article-title":"The role of chemokines in Hodgkin's disease","volume":"38","author":"Teruya-Feldstein","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0395","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/1042819031000060546","article-title":"Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas, Possible migration and autocrine mechanism","volume":"44","author":"Ohshima","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0400","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ijc.20823","article-title":"CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone","volume":"114","author":"Suefuji","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0405","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/ijc.25236","article-title":"Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells","volume":"127","author":"Venetz","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0410","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ncomms1239","article-title":"Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer","volume":"2","author":"Haabeth","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0415","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2003.10.036","article-title":"CXCR3-binding chemokines in multiple myeloma","volume":"207","author":"Pellegrino","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0420","first-page":"1489","article-title":"CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival","volume":"91","author":"Giuliani","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0425","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/leu.2014.121","article-title":"Heparanase enhances myeloma progression via CXCL10 downregulation","volume":"28","author":"Barash","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0430","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2006-04-018770","article-title":"4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4","volume":"109","author":"Cheng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0435","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3324\/haematol.2012.065607","article-title":"Platelet factor 4 induces cell apoptosis by inhibition of STAT3 via up-regulation of SOCS3 expression in multiple myeloma","volume":"98","author":"Liang","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0440","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood.V89.7.2328","article-title":"Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents","volume":"89","author":"Han","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0445","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C\u2013X\u2013C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0450","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/clim.2000.4957","article-title":"CXCR3 and CCR5 ligands in rheumatoid arthritis synovium","volume":"98","author":"Patel","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0455","doi-asserted-by":"crossref","first-page":"R241","DOI":"10.1186\/ar783","article-title":"High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis","volume":"5","author":"Ruschpler","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0460","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00296-007-0317-6","article-title":"Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis","volume":"27","author":"Erdem","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0465","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s100670200123","article-title":"Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis","volume":"21","author":"Yamamoto","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0470","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar1913","article-title":"Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells","volume":"8","author":"Pharoah","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0475","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00296-004-0449-x","article-title":"The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis","volume":"25","author":"Ueno","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0480","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar2678","article-title":"Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis","volume":"11","author":"Badot","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0485","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/187153007780832109","article-title":"CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication","volume":"7","author":"Singh","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00054725-200111000-00001","article-title":"Chemokine receptor CXCR3 expression in inflammatory bowel disease","volume":"7","author":"Yuan","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0495","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.28.3.336","article-title":"Raised plasma concentrations of platelet factor 4 (Pf4) in Crohn's disease","volume":"28","author":"Simi","year":"1987","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0500","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2362.2000.00616.x","article-title":"Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis","volume":"30","author":"Vrij","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0505","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bcp.2006.12.019","article-title":"Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling","volume":"73","author":"Meuwis","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0510","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00535-007-2118-9","article-title":"The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity","volume":"42","author":"Noguchi","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0515","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9440(10)65128-0","article-title":"Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis","volume":"155","author":"Uguccioni","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0520","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/107999003322485099","article-title":"IFN-gamma-inducible chemokines enhance adaptive immunity and colitis","volume":"23","author":"Singh","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0525","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00054725-200411000-00013","article-title":"Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa","volume":"10","author":"Papadakis","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0530","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ibd.21312","article-title":"Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease","volume":"16","author":"Schroepf","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0535","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbrc.2007.09.020","article-title":"Association of a CXCL9 polymorphism with pediatric Crohn's disease","volume":"363","author":"Lacher","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0540","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","article-title":"CXCL10 and type 1 diabetes","volume":"25","author":"Antonelli","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0545","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.24.3.510","article-title":"Elevated serum IP-10 levels observed in type 1 diabetes","volume":"24","author":"Shimada","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0550","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-002-0879-5","article-title":"Serum concentrations of the interferon-gamma-inducible chemokine IP-10\/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease","volume":"45","author":"Nicoletti","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0555","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1464-5491.2008.02577.x","article-title":"Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study","volume":"25","author":"Antonelli","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0560","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00125-003-1134-4","article-title":"Reply to: Serum concentrations of the interferon-alpha-inducible chemokine IP-10\/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease","volume":"46","author":"Rotondi","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0565","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1464-5491.2005.01743.x","article-title":"Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus","volume":"23","author":"Hanifi-Moghaddam","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0570","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.4049\/jimmunol.175.6.3516","article-title":"Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development","volume":"175","author":"Rhode","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0575","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","article-title":"Islet inflammation and CXCL10 in recent-onset type 1 diabetes","volume":"159","author":"Roep","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0580","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2009.02.004","article-title":"Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway","volume":"47","author":"Devaraj","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0585","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/db09-0091","article-title":"Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes","volume":"58","author":"Tanaka","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0590","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2337\/db11-0853","article-title":"Expression and regulation of chemokines in murine and human type 1 diabetes","volume":"61","author":"Sarkar","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0595","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1507\/endocrj.K10E-076","article-title":"Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes","volume":"57","author":"Uno","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0600","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm1202-792","article-title":"Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis","volume":"8","author":"Frigerio","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0605","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.4049\/jimmunol.173.11.7017","article-title":"CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis","volume":"173","author":"Morimoto","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0610","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2009.01.003","article-title":"CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling","volume":"9","author":"Schulthess","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0615","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1900\/RDS.2009.6.81","article-title":"The role of the CXCL10\/CXCR3 system in type 1 diabetes","volume":"6","author":"Shimada","year":"2009","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0620","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0609.1982.tb00581.x","article-title":"Enhanced in vivo platelet activation in diabetes mellitus","volume":"29","author":"Ek","year":"1982","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0625","first-page":"856","article-title":"Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy","volume":"29","author":"Roy","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0630","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exer.2013.01.008","article-title":"Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy","volume":"109","author":"Nawaz","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0635","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/IAE.0b013e3181bd2f44","article-title":"Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy","volume":"30","author":"Wakabayashi","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0640","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0645","first-page":"1833","article-title":"Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis","volume":"18","author":"Lima","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0650","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0923-1811(95)00445-9","article-title":"Plasma levels of molecular markers of blood coagulation and fibrinolysis in progressive systemic sclerosis (PSS)","volume":"11","author":"Maeda","year":"1996","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0655","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/ard.2004.022970","article-title":"Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis","volume":"64","author":"Kowal-Bielecka","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0660","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis \u2013 a longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0665","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","article-title":"Evidence for the involvement of type I interferon in pulmonary arterial hypertension","volume":"114","author":"George","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0670","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-010-1610-4","article-title":"Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis","volume":"30","author":"Hasegawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0675","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"Rabquer","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0680","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdermsci.2004.03.001","article-title":"Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis","volume":"35","author":"Fujii","year":"2004","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0685","first-page":"S71","article-title":"CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis","volume":"30","author":"Sfriso","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0690","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0952-7915(02)00382-5","article-title":"Chemokines: directing leukocyte infiltration into allografts","volume":"14","author":"el-Sawy","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0695","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.cca.2012.02.009","article-title":"CXCL10: a candidate biomarker in transplantation","volume":"413","author":"Romagnani","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0700","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2008.02323.x","article-title":"The puzzling role of CXCR3 and its ligands in organ allograft rejection","volume":"8","author":"Halloran","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e318218e978","article-title":"Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation","volume":"92","author":"Heidt","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0710","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.TP.0000160759.85080.2E","article-title":"High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy","volume":"79","author":"Lazzeri","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0715","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1432-2277.2009.01006.x","article-title":"High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients","volume":"23","author":"Rotondi","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0720","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/TP.0b013e3181919f5d","article-title":"Predictive role of pretransplant serum CXCL10 for cardiac acute rejection","volume":"87","author":"Crescioli","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0725","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2261-6-29","article-title":"Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection","volume":"6","author":"Karason","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0730","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trre.2013.10.004","article-title":"Urine proteomics in kidney transplantation","volume":"28","author":"Kim","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0735","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64126-0","article-title":"Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection","volume":"158","author":"Agostini","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0740","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.4049\/jimmunol.171.9.4844","article-title":"Role of CXCL9\/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection","volume":"171","author":"Belperio","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0745","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1161\/hc4601.098010","article-title":"Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection","volume":"104","author":"Melter","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0750","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.4049\/jimmunol.167.6.3494","article-title":"Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection","volume":"167","author":"Miura","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0755","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/TP.0b013e3181fe12fc","article-title":"Chemokines and their receptors in human renal allotransplantation","volume":"91","author":"Lo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0760","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/00007890-200112270-00016","article-title":"Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants","volume":"72","author":"Goddard","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0765","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jss.2012.07.016","article-title":"Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation","volume":"178","author":"Asaoka","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0770","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-6143.2004.00354.x","article-title":"Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction","volume":"4","author":"Hu","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-005-9010-9","article-title":"Rat chemokine CXCL11: structure, tissue distribution, function and expression in cardiac transplantation models","volume":"296","author":"Mitsuhashi","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0780","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4049\/jimmunol.169.3.1556","volume":"169","author":"Zhao","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0785","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1172\/JCI71858","article-title":"Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection","volume":"124","author":"Shi","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0790","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2006-12-061408","article-title":"CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation","volume":"110","author":"Piper","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0795","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2012-02-413260","article-title":"Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD","volume":"120","author":"Croudace","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0800","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bmt.2009.346","article-title":"Differential chemokine expression in chronic GVHD of the conjunctiva","volume":"45","author":"Westekemper","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0805","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V57.2.199.199","article-title":"Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo","volume":"57","author":"Kaplan","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0810","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1055\/s-0038-1653407","article-title":"Platelet hypersensitivity in acute malaria (Plasmodium falciparum) infection in man","volume":"46","author":"Essien","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0815","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000206720","article-title":"Platelet secretory activities in acute malaria (Plasmodium falciparum) infection","volume":"70","author":"Essien","year":"1983","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0820","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1155\/2011\/345706","article-title":"Potential serological biomarkers of cerebral malaria","volume":"31","author":"Lucchi","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0825","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/eji.200737906","article-title":"CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines","volume":"38","author":"Van den Steen","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0830","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1475-2875-6-147","article-title":"Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children","volume":"6","author":"Armah","year":"2007","journal-title":"Malar J"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0835","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1155\/2011\/828256","article-title":"CXCL4 and CXCL10 predict risk of fatal cerebral malaria","volume":"30","author":"Wilson","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0840","doi-asserted-by":"crossref","first-page":"e81329","DOI":"10.1371\/journal.pone.0081329","article-title":"CXCL10 gene promoter polymorphism \u22121447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria","volume":"8","author":"Wilson","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0845","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.4049\/jimmunol.178.9.5779","article-title":"NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria","volume":"178","author":"Hansen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0850","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4049\/jimmunol.180.2.1217","article-title":"Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency","volume":"180","author":"Miu","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0855","doi-asserted-by":"crossref","first-page":"e1000369","DOI":"10.1371\/journal.ppat.1000369","article-title":"IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection","volume":"5","author":"Nie","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0860","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.chom.2008.07.003","article-title":"Platelet factor 4 mediates inflammation in experimental cerebral malaria","volume":"4","author":"Srivastava","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0865","doi-asserted-by":"crossref","first-page":"e10413","DOI":"10.1371\/journal.pone.0010413","article-title":"Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria","volume":"5","author":"Srivastava","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0870","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actatropica.2011.04.020","article-title":"Plasmodium berghei NK65 induces cerebral leukocyte recruitment in vivo: an intravital microscopic study","volume":"120","author":"Lacerda-Queiroz","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0875","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/eji.201343327","article-title":"Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA","volume":"43","author":"Palomo","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0880","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1073\/pnas.0801544105","article-title":"Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria","volume":"105","author":"Campanella","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0885","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/IAI.00810-10","article-title":"Beta interferon suppresses the development of experimental cerebral malaria","volume":"79","author":"Morrell","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0890","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.chom.2012.10.017","article-title":"Platelet Factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials","volume":"12","author":"Love","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0895","doi-asserted-by":"crossref","DOI":"10.4161\/cib.23653","article-title":"New insights into the protective power of platelets in malaria infection","volume":"6","author":"McMorran","year":"2013","journal-title":"Commun Integr Biol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0900","doi-asserted-by":"crossref","first-page":"25348","DOI":"10.1074\/jbc.270.43.25348","article-title":"Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor","volume":"270","author":"Szabo","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0905","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1166296","article-title":"Platelets kill intraerythrocytic malarial parasites and mediate survival to infection","volume":"323","author":"McMorran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0910","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1126\/science.1228892","article-title":"Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum","volume":"338","author":"McMorran","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0915","first-page":"412","article-title":"Roles of chemokines and chemokine receptors in HIV-1 infection","volume":"72","author":"Murakami","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0920","doi-asserted-by":"crossref","first-page":"e1000520","DOI":"10.1371\/journal.ppat.1000520","article-title":"Chemokine coreceptor signaling in HIV-1 infection and pathogenesis","volume":"5","author":"Wu","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0925","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1128\/JVI.01941-06","article-title":"Modest human immunodeficiency virus coreceptor function of CXCR3 is strongly enhanced by mimicking the CXCR4 ligand binding pocket in the CXCR3 receptor","volume":"81","author":"Hatse","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0930","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1097\/QAI.0b013e3182930ea8","article-title":"Plasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals","volume":"63","author":"Gray","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0935","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1600-0684.2003.00031.x","article-title":"Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"32","author":"Sarkar","year":"2003","journal-title":"J Med Primatol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0940","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1086\/421244","article-title":"Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection","volume":"189","author":"Shacklett","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0945","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jneuroim.2005.07.002","article-title":"Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection","volume":"168","author":"Cinque","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0950","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0165-5728(98)00223-9","article-title":"Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10","volume":"93","author":"Kolb","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0955","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm822","article-title":"HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages","volume":"9","author":"Izmailova","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0960","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.4049\/jimmunol.174.8.4892","article-title":"Roles for CXC chemokine ligands 10 and 11 in recruiting CD4+ T cells to HIV-1-infected monocyte-derived macrophages, dendritic cells, and lymph nodes","volume":"174","author":"Foley","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0965","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/viro.2001.1249","article-title":"The effect of X4 and R5 HIV-1 on C, C\u2013C, and C\u2013X\u2013C chemokines during the early stages of infection in human PBMCs","volume":"292","author":"Wetzel","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0970","doi-asserted-by":"crossref","first-page":"7067","DOI":"10.1128\/JVI.75.15.7067-7077.2001","article-title":"Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10\/IP-10 gene expression by astrocytes in vivo and in vitro","volume":"75","author":"Asensio","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0975","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0165-5728(01)00413-1","article-title":"The regulation of alpha chemokines during HIV-1 infection and leukocyte activation: relevance for HIV-1-associated dementia","volume":"120","author":"Poluektova","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0980","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1742-2094-9-239","article-title":"Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator","volume":"9","author":"Mehla","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0985","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.virol.2004.08.024","article-title":"Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10","volume":"329","author":"van Marle","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0990","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1471-4906(03)00163-7","article-title":"Chemokine induction by HIV-1: recruitment to the cause","volume":"24","author":"Reinhart","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib0995","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0042-6822(02)00045-4","article-title":"The C\u2013X\u2013C chemokine IP-10 stimulates HIV-1 replication","volume":"307","author":"Lane","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1000","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.1073\/pnas.1207314109","article-title":"Identification of the platelet-derived chemokine CXCL4\/PF-4 as a broad-spectrum HIV-1 inhibitor","volume":"109","author":"Auerbach","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-4690-10-48","article-title":"Platelet activation suppresses HIV-1 infection of T cells","volume":"10","author":"Tsegaye","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1010","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QAI.0b013e3180559219","article-title":"Interferon gamma-inducible protein 10: a predictive marker of successful treatment response in hepatitis C virus\/HIV-coinfected patients","volume":"45","author":"Zeremski","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2172-13-15","article-title":"The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10","volume":"13","author":"Qu","year":"2012","journal-title":"BMC Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2011.10.020","article-title":"High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV\/HCV coinfected patients","volume":"57","author":"Berenguer","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1025","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/520935","article-title":"Elevated serum levels of interferon-gamma-inducible protein-10 in patients coinfected with hepatitis C virus and HIV","volume":"196","author":"Roe","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1030","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1183\/09031936.00039010","article-title":"Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients","volume":"36","author":"Aabye","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAD.0b013e328334895e","article-title":"Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients","volume":"24","author":"Kabeer","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ajh.23200","article-title":"Relationship between inflammatory mediator patterns and anemia in HIV-1 positive and exposed children with Plasmodium falciparum malaria","volume":"87","author":"Davenport","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1045","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1128\/IAI.70.12.6524-6533.2002","article-title":"Antimicrobial peptides from human platelets","volume":"70","author":"Tang","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4049\/jimmunol.167.2.623","article-title":"Cutting edge: IFN-inducible ELR-negative CXC chemokines display defensin-like antimicrobial activity","volume":"167","author":"Cole","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1055","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.4049\/jimmunol.166.3.1790","article-title":"Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system","volume":"166","author":"Liu","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1060","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4049\/jimmunol.165.5.2327","article-title":"The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease","volume":"165","author":"Liu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/cmi.2013.37","article-title":"The role of chemokines in acute and chronic hepatitis C infection","volume":"11","author":"Fahey","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1070","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.14.7149","article-title":"Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection","volume":"14","author":"Larrubia","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1189\/jlb.0303093","article-title":"Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation","volume":"74","author":"Harvey","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jgh.12462","article-title":"Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression","volume":"29","author":"Nguyen","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1085","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1111\/j.1572-0241.2002.07054.x","article-title":"Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease","volume":"97","author":"Apolinario","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1090","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/646614","article-title":"Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection","volume":"200","author":"Zeremski","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","article-title":"Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans","volume":"137","author":"Wasmuth","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.26069","article-title":"Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes","volume":"57","author":"Sahin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1105","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.20167","article-title":"Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation","volume":"39","author":"Helbig","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1110","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/hep.22500","article-title":"Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C","volume":"48","author":"Zeremski","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1115","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.23435","article-title":"CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis","volume":"51","author":"Zaldivar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1120","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1125","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2011.02504.x","article-title":"Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases","volume":"31","author":"Tacke","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1130","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI6993","article-title":"Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells","volume":"104","author":"Mach","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.yexmp.2007.02.008","article-title":"VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins","volume":"83","author":"Anger","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1140","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/CIRCULATIONAHA.106.631457","article-title":"Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells","volume":"114","author":"Ranjbaran","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1145","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.105.605121","article-title":"Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells","volume":"113","author":"Heller","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1150","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1160\/TH07-04-0271","article-title":"Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl\/6 and apoE\u2212\/\u2212 mice","volume":"98","author":"Sachais","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm.1898","article-title":"Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice","volume":"15","author":"Koenen","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1160\/TH10-03-0193","article-title":"Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis","volume":"104","author":"Aidoudi","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1165","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.4049\/jimmunol.0901368","article-title":"CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages","volume":"184","author":"Gleissner","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1170","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1074\/jbc.M208894200","article-title":"Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells","volume":"278","author":"Nassar","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1175","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH03-02-0069","article-title":"Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters","volume":"90","author":"Pitsilos","year":"2003","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1152\/physiolgenomics.00104.2007","article-title":"Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease","volume":"31","author":"Ardigo","year":"2007","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","article-title":"Neuroinflammatory processes in Alzheimer's disease","volume":"117","author":"Heneka","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/13550289909029743","article-title":"Chemokines\/chemokine receptors in the central nervous system and Alzheimer's disease","volume":"5","author":"Xia","year":"1999","journal-title":"J Neurovirol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(00)00285-X","article-title":"Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1\/2 activation and role in Alzheimer's disease","volume":"108","author":"Xia","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1200","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1460-9568.2006.04631.x","article-title":"CXCL10-induced cell death in neurons: role of calcium dysregulation","volume":"23","author":"Sui","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/pr300895r","article-title":"Secretome analyses of Abeta(1\u201342) stimulated hippocampal astrocytes reveal that CXCL10 is involved in astrocyte migration","volume":"12","author":"Lai","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1212\/01.wnl.0000191324.08289.9d","article-title":"Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration","volume":"66","author":"Galimberti","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","article-title":"Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease","volume":"63","author":"Galimberti","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1220","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/j.1468-1331.2006.01637.x","article-title":"IP-10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease","volume":"14","author":"Galimberti","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1225","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11064-007-9554-z","article-title":"Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice","volume":"33","author":"Duan","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000330468","article-title":"Two blood monocytic biomarkers (CCL15 and p21) combined with the mini-mental state examination discriminate Alzheimer's disease patients from healthy subjects","volume":"1","author":"Hochstrasser","year":"2011","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.imlet.2008.09.004","article-title":"Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment","volume":"121","author":"Lee","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1240","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1074\/jbc.M006285200","article-title":"Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C","volume":"276","author":"Skovronsky","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/JBM.S45071","article-title":"Contribution of blood platelets to vascular pathology in Alzheimer's disease","volume":"4","author":"Zhang","year":"2013","journal-title":"J Blood Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1250","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1073\/pnas.0334864100","article-title":"Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines","volume":"100","author":"Proudfoot","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1255","first-page":"11","article-title":"Emphasis on the role of PF4 in the incidence, pathophysiology and treatment of heparin induced thrombocytopenia","author":"Prechel","year":"2013","journal-title":"Thromb J"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1260","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","article-title":"Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Rauova","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1566523043346228","article-title":"Cancer gene therapy through autonomous parvovirus-mediated gene transfer","volume":"4","author":"Cornelis","year":"2004","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1270","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1096\/fj.00-0285fje","article-title":"A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2","volume":"15","author":"Hagedorn","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1275","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1158\/1541-7786.MCR-09-0176","article-title":"The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1\/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo","volume":"8","author":"Vandercappellen","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1280","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00262-010-0901-6","article-title":"Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy","volume":"59","author":"Wang","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1285","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1096\/fj.02-0509fje","article-title":"The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models","volume":"16","author":"van der Schaft","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1290","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/gutjnl-2012-303424","article-title":"Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study","volume":"63","author":"Mayer","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1295","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.34330","article-title":"A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis","volume":"64","author":"Yellin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1300","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/092986712798918770","article-title":"Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation","volume":"19","author":"Nagy","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1305","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1055\/s-0030-1255450","article-title":"Recombinant platelet factor 4: a therapeutic, anti-neoplastic chimera","volume":"36","author":"Lippi","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1310","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1568008053174723","article-title":"CXCR3-binding chemokines: novel multifunctional therapeutic targets","volume":"5","author":"Lazzeri","year":"2005","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/187153007780059405","article-title":"Chemokines as drug targets in type 1 diabetes","volume":"7","author":"Christen","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1320","doi-asserted-by":"crossref","first-page":"e31343","DOI":"10.1371\/journal.pone.0031343","article-title":"PF-4var\/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function","volume":"7","author":"De Sutter","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1325","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.clinbiochem.2008.04.021","article-title":"Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study","volume":"41","author":"Meuwis","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1330","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/ard.2008.093153","article-title":"Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis","volume":"68","author":"Trocme","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1335","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","article-title":"Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection","volume":"194","author":"Romero","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1340","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/00365548.2010.498019","article-title":"IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV","volume":"42","author":"Falconer","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1345","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI40594","article-title":"Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV","volume":"121","author":"Casrouge","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2013.04.016","article-title":"CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients","volume":"63","author":"Ragab","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1355","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V98.13.3554","article-title":"Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties","volume":"98","author":"Proost","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1360","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1365","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1016\/S0021-9258(17)37123-5","article-title":"Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor","volume":"269","author":"Chaudhuri","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1370","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbrc.2004.06.146","article-title":"The human Duffy antigen binds selected inflammatory but not homeostatic chemokines","volume":"321","author":"Gardner","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1375","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.biopha.2011.12.003","article-title":"The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma","volume":"66","author":"Wu","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1380","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.92.17.7799","article-title":"A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4","volume":"92","author":"Gupta","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-291X(05)81398-1","article-title":"Induction of members of the IL-8\/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A","volume":"181","author":"Zipfel","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1390","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1158\/0008-5472.CAN-06-4682","article-title":"Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis","volume":"67","author":"Struyf","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1395","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1016\/j.vaccine.2008.08.012","article-title":"The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10","volume":"26","author":"Lu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1400","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.0906-6705.2004.00191.x","article-title":"IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency","volume":"13","author":"Keyser","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1405","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jnci\/82.10.848","article-title":"Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4","volume":"82","author":"Sharpe","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1410","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jnci\/87.4.304","article-title":"Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4","volume":"87","author":"Kolber","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1415","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00262-001-0231-9","article-title":"Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10\/CXCL10)","volume":"50","author":"Arenberg","year":"2001","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1420","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1158\/1078-0432.CCR-04-2117","article-title":"Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors","volume":"11","author":"Li","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1425","first-page":"909","article-title":"Expression of the Mig (CXCL9) gene in murine lung carcinoma cells generated angiogenesis-independent antitumor effects","volume":"10","author":"Wang","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1430","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.gt.3302756","article-title":"Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma","volume":"13","author":"Zhang","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1435","first-page":"8498","article-title":"MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma","volume":"61","author":"Ruehlmann","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1440","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4049\/jimmunol.176.3.1456","article-title":"CXCR3\/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis","volume":"176","author":"Pan","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1445","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/CJI.0b013e318031b551","article-title":"Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model","volume":"30","author":"Walser","year":"2007","journal-title":"J Immunother"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1450","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/104303401750476221","article-title":"Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites","volume":"12","author":"Hampl","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1455","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3892\/or.2012.1853","article-title":"Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels","volume":"28","author":"Yang","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1460","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1016\/j.vaccine.2009.08.002","article-title":"Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma","volume":"27","author":"Jiang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1465","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ymthe.2006.07.011","article-title":"Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy","volume":"14","author":"Liu","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1470","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/cgt.2008.62","article-title":"TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10\/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma","volume":"16","author":"Enderlin","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1475","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/neuonc\/not317","article-title":"Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus","volume":"16","author":"Antoszczyk","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1480","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00432-007-0337-3","article-title":"Synergistic antitumor effect of CXCL10 with hyperthermia","volume":"134","author":"Chen","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1485","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/sj.cgt.7700457","article-title":"Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice","volume":"9","author":"Giese","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1490","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood.V89.8.2635","article-title":"Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo","volume":"89","author":"Sgadari","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2014.11.009_bib1495","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.cji.0000165355.26795.27","article-title":"The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis","volume":"28","author":"Hensbergen","year":"2005","journal-title":"J Immunother"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610114001634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610114001634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T04:14:41Z","timestamp":1717560881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610114001634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":299,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1359610114001634"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2014.11.009","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCR3 ligands in disease and therapy","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2014.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}